🔗 Share this article

The Nobel Prize in medical science has been awarded for transformative discoveries that clarify how the body's defense network targets dangerous pathogens while sparing the healthy tissues.

A trio of renowned researchers—from Japan Prof. Sakaguchi and American scientists Mary Brunkow and Fred Ramsdell—received this accolade.

The research uncovered specialized "sentinels" within the immune system that eliminate rogue defense cells capable of attacking the organism.

These discoveries are now enabling innovative treatments for immune disorders and cancer.

The winners will divide a prize fund valued at 11m Swedish kronor.

Crucial Discoveries

"Their work has been essential for comprehending how the body's defenses operates and the reason we don't all develop serious autoimmune diseases," stated the chair of the award panel.

The trio's research explain a core question: How does the defense system protect us from numerous infections while keeping our healthy cells intact?

Our immune system uses white blood cells that scan for signs of disease, even pathogens and germs it has not met before.

These cells employ detectors—called recognition units—that are generated by chance in a vast number of variations.

That gives the immune system the capacity to combat a broad range of invaders, but the randomness of the process inevitably produces immune cells that may attack the host.

Protectors of the Body

Scientists earlier understood that a portion of these problematic defense cells were eliminated in the immune organ—where immune cells develop.

The latest award honors the discovery of regulatory T-cells—known as the body's "security guards"—which travel through the system to disarm any immune cells that assault the body's own tissues.

We know that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, MS, and rheumatoid arthritis.

A Nobel panel stated, "The discoveries have laid the foundation for a novel area of research and spurred the development of new therapies, for instance for tumors and immune disorders."

In malignancies, T-regs prevent the body from attacking the tumor, so research are aimed at lowering their quantity.

In autoimmune diseases, trials are exploring boosting T-reg cells so the organism is no longer under attack. A comparable method could also be useful in minimizing the chances of organ transplant rejection.

Pioneering Studies

Professor Shimon Sakaguchi, from a Japanese institution, performed tests on mice that had their immune gland removed, leading to self-attack conditions.

The researcher demonstrated that introducing immune cells from healthy mice could prevent the illness—implying there was a system for blocking defenders from attacking the body.

Dr. Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, currently at a biotech firm in San Francisco, were investigating an inherited autoimmune disease in rodents and people that led to the identification of a genetic factor vital for how T-regs operate.

"Their groundbreaking work has uncovered how the body's defenses is controlled by regulatory T cells, preventing it from accidentally targeting the body's own tissues," commented a leading biological science expert.

"The work is a remarkable illustration of how fundamental biological research can have broad consequences for human health."